Condition

Sintilimab clinical trials and research

• 8Clinical trials
• 1Country

Newest Sintilimab clinical trials

All recruiting trials (8)

• Sintilimab + ipilimumab N01 with cetuximab and dabrafenib for MSS BRAF V600E metastatic colorectal cancer

  This trial will test whether combining the immunotherapies sintilimab and ipilimumab N01 with cetuximab and dabrafenib helps people with microsatellite-stable, BRAF V600E metastatic colorectal cancer live longer or have better tumor control.

  Recruiting Phase 2 Tianjin Medical University Cancer Institute and Hospital · Beijing, Beijing Municipality and 3 other locations · NCT07506109

• Thiotepa with pirtobrutinib and sintilimab for frail or relapsed/refractory CNS lymphoma

  This treatment combines thiotepa with pirtobrutinib and sintilimab for adults who are frail or whose primary or secondary central nervous system lymphoma has relapsed or not responded to prior therapy.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07416890

• Sintilimab plus bevacizumab biosimilar before surgery for resectable liver cancer

  This trial will test whether giving sintilimab together with a bevacizumab biosimilar before surgery helps people with resectable hepatocellular carcinoma beyond the Milan criteria.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07324824

• Combining PD‑1 immunotherapy (sintilimab) with platinum‑doublet chemotherapy and adaptive radiotherapy for stage III non‑small cell lung cancer

  This study tests whether adding the PD‑1 drug sintilimab to standard platinum‑doublet chemotherapy plus adaptive radiotherapy helps people with unresectable stage III non‑small cell lung cancer.

  Recruiting at 4 sites Phase 2 The Third Xiangya Hospital of Central South University · Changsha, Hunan and 3 other locations · NCT07138755

• Combining low dose radiotherapy with immunotherapy and chemotherapy for lung cancer treatment

  This study is testing whether a combination of low dose radiation, immunotherapy, and chemotherapy can help people with stage II-III non-small cell lung cancer do better before surgery.

  Recruiting Phase 2 Anhui Provincial Cancer Hospital · Hefei, Anhui · NCT06714708

• Using sintilimab after chemoradiotherapy for elderly patients with esophageal cancer

  This study is testing if adding a new treatment called sintilimab after chemotherapy and radiation can help older patients with esophageal cancer live longer and healthier.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06413342

• Immunotherapy with radiotherapy and nutrition support for advanced esophageal cancer in patients who can’t tolerate standard chemoradiation

  This trial tests whether adding a PD-1 inhibitor (sintilimab) to radiotherapy plus specialized nutrition helps patients with locally advanced esophageal squamous cell carcinoma who can’t tolerate standard chemoradiation.

  Recruiting at 10 sites Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality and 9 other locations · NCT06342167

• Combining Sintilimab with Chemoradiotherapy for High-risk Nasopharyngeal Cancer

  This study is testing a new treatment plan that combines a cancer drug called Sintilimab with chemotherapy and radiation to see if it helps people with high-risk nasopharyngeal cancer.

  Recruiting Cancer Hospital of Guangxi Medical University · Nanning, Guangxi · NCT05707819

Related topics

Quick answers

How many Sintilimab clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 7. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →